Wordt geladen...
Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer
Erlotinib hydrochloride (Tarceva(®)) is a member of a class of small molecule inhibitors that targets the tyrosine kinase domain of the epidermal growth factor receptor (EGFR), with anti-tumor activity in preclinical models. Erlotinib represents a new-generation of agents known as “targeted therapie...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3004579/ https://ncbi.nlm.nih.gov/pubmed/21188105 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|